000			03096nam a22003735i 4500
999			_c88235 _d88235 _x1
001			88235
003			ES-MaUEC
005			20230207040628.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			161221s2016 gw | s |||| 0|eng d
020			_a9783319480664
024	7		_a10.1007/978-3-319-48066-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC271.I45 _b2016 EB
100	1		_aRotte, Anand _9101809
245	1	0	_aImmunotherapy of Melanoma _cby Anand Rotte, Madhuri Bhandaru
264		1	_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XI, 434 páginas) _b59 ilustraciones, 52 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aPreface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.
520			_aThis book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy.
988			_aEBOOK, EBSPRINGER
650		7	_aCáncer _xInmunoterapia _2embne _9348509
650		7	_aOncología _2embne _9139207
700	1		_aBhandaru, Madhuri _0Local _9101810
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-48066-4zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12982398 _b10-10-17 _c08-03-17
942			_2lcc _cLE
945			_g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11604232 _z06-04-17
998			_b06/2020 _dz _eu _feng _ggw _h0